Current Unmet Needs in ccRCC Diagnosis

Current Gaps in Renal Mass Imaging

Main Discussion Topics:

• Current imaging cannot reliably predict tumor biology or aggressiveness.
• Need for imaging techniques that can identify aggressive lesions requiring immediate intervention
• Comparison to advances in prostate cancer with molecular imaging (prostate-specific membrane antigen [PSMA] PET)
• Desire for similar molecular imaging paradigms in kidney cancer

Key Points for Physicians:

• Contemporary imaging provides anatomic and enhancement information but limited biological insights.
• The ability to predict which tumors will become aggressive remains a significant gap.
• Prostate cancer imaging has evolved to routinely include molecular imaging (PSMA PET).
• Similar developments are needed in kidney cancer imaging.

Notable Insights:

There is a significant need for imaging that predicts biological behavior rather than just providing anatomic information.

Clinical Significance:

Developing imaging that predicts tumor biology could prevent overtreatment of indolent tumors and ensure appropriate intervention for aggressive ones.